The PE Ratio as of December 2024 (TTM) for NovaBay Pharmaceuticals, Inc. (NBY) is -0.01

According to NovaBay Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -96.55% compared to the average of -0.29 of the last 4 quarters.

NovaBay Pharmaceuticals, Inc. (NBY) Historical PE Ratio (quarterly & annually)

How has NBY PE Ratio performed in the past?

The mean historical PE Ratio of NovaBay Pharmaceuticals, Inc. over the last ten years is -1.55. The current -0.01 PE Ratio has changed -35.56% with respect to the historical average. Over the past ten years (40 quarters), NBY's PE Ratio was at its highest in in the December 2017 quarter at 18.66. The PE Ratio was at its lowest in in the March 2022 quarter at -33.42.

NovaBay Pharmaceuticals, Inc. (NBY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NovaBay Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NovaBay Pharmaceuticals, Inc. (NBY) Average PE Ratio

How has NBY PE Ratio performed in the past?

The current PE Ratio of NovaBay Pharmaceuticals, Inc. (NBY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NovaBay Pharmaceuticals, Inc. (NBY) PE Ratio vs. Peers

How is NBY’s PE Ratio compared to its peers?

NovaBay Pharmaceuticals, Inc.’s PE Ratio is greater than Immix Biopharma, Inc. (-2.93), greater than CNS Pharmaceuticals, Inc. (-0.14), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Navidea Biopharmaceuticals, Inc. (0.00), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.18), less than ZyVersa Therapeutics, Inc. (-0.00), greater than VectivBio Holding AG (-7.94), less than AVROBIO, Inc. (2.07), greater than Zura Bio Limited (-4.88), greater than Altamira Therapeutics Ltd. (-0.02), greater than Enveric Biosciences, Inc. (-0.27), greater than Palisade Bio, Inc. (-0.19), greater than Phio Pharmaceuticals Corp. (-0.30),

Build a custom stock screener for NovaBay Pharmaceuticals, Inc. (NBY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBay Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovaBay Pharmaceuticals, Inc. (NBY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovaBay Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.